In gastric cancer, the overexpression of SCIN is associated with poor overall survival rate (6), and it changes significantly in stages I and IV, stage II and IV, and stage III and IV (7), which may promote the progression of gastric cancer by regulating STAT3 and NF-κB signaling (8). This evidence concerns the gene STAT3 and gastric cancer.